Jasper Therapeutics
JSPR
JSPR
22 hedge funds and large institutions have $9.57M invested in Jasper Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
39% less capital invested
Capital invested by funds: $15.7M → $9.57M (-$6.18M)
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$76.1K | |
| 2 | +$18K | |
| 3 | +$16.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.7K |
| 5 |
Millennium Management
New York
|
+$14K |
Top Sellers
| 1 | -$316K | |
| 2 | -$2.8K | |
| 3 | -$2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$393 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$146 |